Relationship between characteristics of medications and drug-induced liver disease phenotype and outcome. - Wikidata - wikimedia - TriplyDB

Relationship between characteristics of medications and drug-induced liver disease phenotype and outcome.

Relationship between characteristics of medications and drug-induced liver disease phenotype and outcome.

http://www.wikidata.org/entity/Q33784830

about

Hepatobiliary Quiz (Answers)-16 (2015).BDDCS Predictions, Self-Correcting Aspects of BDDCS Assignments, BDDCS Assignment Corrections, and Classification for more than 175 Additional Drugs.Caspase 3 role and immunohistochemical expression in assessment of apoptosis as a feature of H1N1 vaccine-caused Drug-Induced Liver Injury (DILI).BDDCS, the Rule of 5 and drugability.Use of the Biopharmaceutics Drug Disposition Classification System (BDDCS) to Help Predict the Occurrence of Idiosyncratic Cutaneous Adverse Drug Reactions Associated with Antiepileptic Drug Usage Evaluation of DILI Predictive Hypotheses in Early Drug Development.A Model to predict severity of drug-induced liver injury in humans.

P2860

Q36492514-0C5C2B06-400B-4D28-A3CE-DA65F1D0A931 Q38640797-CB783831-199D-47DB-AC1A-CC9AB4996660 Q38676495-37897BEC-5586-4639-BE75-1DABEA264595 Q38835159-B13FFD88-21BB-46D0-A66A-147B34DECE1D Q39941531-33A43BBD-5155-4F1F-A5EF-9E1A2836400C Q46268821-FCDB349B-426B-4D99-92EF-F87CECD6F071 Q50627145-B8324CA2-339E-4949-8E0B-3A692840F65E

P2860

Relationship between characteristics of medications and drug-induced liver disease phenotype and outcome.

http://www.wikidata.org/entity/Q33784830

description

2013 nî lūn-bûn

@nan

2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Relationship between character ...... disease phenotype and outcome.

@ast

Relationship between character ...... disease phenotype and outcome.

@en

type

label

Relationship between character ...... disease phenotype and outcome.

@ast

Relationship between character ...... disease phenotype and outcome.

@en

prefLabel

Relationship between character ...... disease phenotype and outcome.

@ast

Relationship between character ...... disease phenotype and outcome.

@en

P1433

Q33784830-229A087B-7917-4DEB-AE33-82F6930C383A

P1476

Q33784830-01ACDA5B-F632-42CA-93FD-6C8567E812E8

P2093

Q33784830-00AF497D-2012-44B7-9330-B645AD1CF081

Q33784830-0D2E0D69-3CAF-48DF-80AF-A5D822A0323D

Q33784830-7AC82166-4041-4272-B965-4B6A4CAF3E3B

Q33784830-AE16BCA1-B0B9-4723-818B-21F14A774FED

Q33784830-B5D3C426-FB08-4F2E-9664-F042735ECDAB

Q33784830-C8338349-7995-42B9-A081-77E36E5C8876

Q33784830-DFDBB312-05B1-44BE-ABA9-57DA2B590020

P2860

Q33784830-1F55AEE4-CDBB-4706-80EB-5FF7383C433B

Q33784830-33042899-6535-4355-8D40-B4A911045250

Q33784830-3D4753A5-ACE0-496A-96CA-B768EF783E7C

Q33784830-43BA70CE-5DF5-4389-8266-730C25EF1BD5

Q33784830-457661BA-9EEF-4AB2-9B39-96D297454012

Q33784830-4688E48E-F560-49F6-896A-5A4EF2F7D1B8

Q33784830-6904CF53-E09B-4079-80DA-B41BA16B303B

Q33784830-741239FF-284E-4518-90AE-D8FBC0E8B884

Q33784830-80D7D526-46FB-44CF-8058-3861696D709E

Q33784830-84A9129E-2BBD-4E21-80E0-D6FA90A779BB

P304

Q33784830-2B012D26-647D-4E59-B33C-E5730F78C532

P31

Q33784830-B7A87420-D08B-4777-BB42-BD40C518CBE8

P356

Q33784830-14361B8F-A758-4422-A822-85B00DB74CE6

P407

Q33784830-88385674-1C1B-4D6F-9ED5-3A4C0A0F542A

P433

Q33784830-F6F784B4-2EC8-481A-B756-DBA5643B64A0

P478

Q33784830-95118DA9-9AF5-4F8E-8F5A-39BB2B7956A2

P50

Q33784830-7793BFB4-B679-4C3B-B39A-330558432709

Q33784830-FB15F2B4-BE2F-419C-A50E-0DC919F9CE1D

P577

Q33784830-83B4D144-3DF8-41E8-B7EE-33DC85E92041

P5875

Q33784830-09A663CB-1140-41B3-AD99-20806E30D4FE

P698

Q33784830-17CCF718-8128-4261-BFEF-0EA7C6BE2F7F

P921

Q33784830-5D0CEB1C-0312-42BD-AB72-1C18C5D2E912

P932

Q33784830-6AE34FA7-B6F1-4543-B3D1-56A6C9F62973

P356

J.CGH.2013.12.016

P1433

Clinical Gastroenterology and Hepatology

P1476

Relationship between character ...... disease phenotype and outcome

@en

P2093

Andrzej S Kosinski

http://www.w3.org/2001/XMLSchema#string

Jiezhun Gu

http://www.w3.org/2001/XMLSchema#string

Jose Serrano

http://www.w3.org/2001/XMLSchema#string

K Rajender Reddy

http://www.w3.org/2001/XMLSchema#string

Naga Chalasani

http://www.w3.org/2001/XMLSchema#string

Raghavender Gotur

http://www.w3.org/2001/XMLSchema#string

Robert J Fontana

http://www.w3.org/2001/XMLSchema#string

P2860

HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin.

Mechanisms of drug-induced liver injury: from bedside to bench.

BDDCS applied to over 900 drugs.

Predicting drug disposition via application of BCS: transport/absorption/ elimination interplay and development of a biopharmaceutics drug disposition classification system.

Physiochemical drug properties associated with in vivo toxicological outcomes.

Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles.

Idiosyncratic drug reactions: current understanding.

The use of BDDCS in classifying the permeability of marketed drugs.

Limited contribution of common genetic variants to risk for liver injury due to a variety of drugs.

Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct.

P304

1550-1555

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CGH.2013.12.016

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Raj Vuppalanchi

P577

2013-12-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259448789

http://www.w3.org/2001/XMLSchema#string

P698

24362054

http://www.w3.org/2001/XMLSchema#string

P921

P932

4065228

http://www.w3.org/2001/XMLSchema#string